Therapeutic agent for herniated intervertebral disc
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 16, 2000
Grant Date -
N/A
app pub date -
Aug 20, 1998
filing date -
Aug 22, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutical composition and an agent that can be used for treatment of epidurally migrating herniated intervertebral disc are provided. The composition comprises a glycosaminoglycan degrading enzyme, preferably chondroitinase, more preferably chondroitinase ABC, in an amount effective to dissolve nucleus pulposus epidurally existing.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully